CONSTULOSE Drug Patent Profile
Which patents cover Constulose, and what generic alternatives are available?
Constulose is a drug marketed by Actavis Mid Atlantic and is included in one NDA.
The generic ingredient in CONSTULOSE is lactulose. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Constulose
A generic version of CONSTULOSE was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CONSTULOSE?
- What are the global sales for CONSTULOSE?
- What is Average Wholesale Price for CONSTULOSE?
Summary for CONSTULOSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 40 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,431 |
| Drug Prices: | Drug price information for CONSTULOSE |
| Drug Sales Revenues: | Drug sales revenues for CONSTULOSE |
| DailyMed Link: | CONSTULOSE at DailyMed |
Recent Clinical Trials for CONSTULOSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tampa General Hospital | Phase 4 |
US Patents and Regulatory Information for CONSTULOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | CONSTULOSE | lactulose | SOLUTION;ORAL | 070288-001 | Aug 15, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
